Events Partner Content Cell and Gene Therapy Manufacturing Forum Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.
News Obesity biotech Kalohexis files confidential IPO Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.